Indeed, xCT is overexpressed by tumors of various histotypes, including breast and colorectal cancer, two of the most common cancer types, and regulates cell invasiveness and resistance to conventional treatments by contributing to the maintenance of intracellular glutathione (GSH) reserves, thus protecting against excessive ROS accumulation [4]. Here, SLC7A11 is linked to cancer.